Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies.

Literature DB >> 20456756

Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies.

M Verso, G Gussoni, G Agnelli.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2010 PMID： 20456756 DOI： 10.1111/j.1538-7836.2010.03901.x

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.

Authors: Zhen Wang; Hong-Hong Yan; Jin-Ji Yang; Bin-Chao Wang; Hua-Jun Chen; Qing Zhou; Chong-Rui Xu; Ben-Yuan Jiang; Yi-Long Wu
Journal: Support Care Cancer Date: 2014-08-27 Impact factor: 3.603

Review 2. Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

Authors: Minh Phan; Sonia John; Ana I Casanegra; Suman Rathbun; Aaron Mansfield; Julie A Stoner; Alfonso J Tafur
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

3. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.

Authors: Taxiarchis V Kourelis; Ewa M Wysokinska; Yi Wang; Ping Yang; Aaron S Mansfield; Alfonso J Tafur
Journal: Lung Cancer Date: 2014-10-12 Impact factor: 5.705

Review 4. Bemiparin in oncology.

Authors: Manuel Monreal Bosch; Alfonso Vignoli; Ramón Lecumberri Villamediana; Paolo Prandoni
Journal: Drugs Date: 2010-12-14 Impact factor: 9.546

5. Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.

Authors: Valentin Fuster; Deepak L Bhatt; Robert M Califf; Alan D Michelson; Marc S Sabatine; Dominick J Angiolillo; Eric R Bates; David J Cohen; Barry S Coller; Bruce Furie; Jean-Sebastien Hulot; Kenneth G Mann; Jessica L Mega; Kiran Musunuru; Christopher J O'Donnell; Matthew J Price; David J Schneider; Daniel I Simon; Jeffrey I Weitz; Marlene S Williams; W Keith Hoots; Yves D Rosenberg; Ahmed A K Hasan
Journal: Circulation Date: 2012-09-25 Impact factor: 29.690

6. Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials.

Authors: Fausto Petrelli; Sandro Barni
Journal: Med Oncol Date: 2013-06-28 Impact factor: 3.064

Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies.

1. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.

Review 2. Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

3. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.

Review 4. Bemiparin in oncology.

5. Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.

6. Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials.

7. Evidence-based guidance on venous thromboembolism in patients with solid tumours.

Review 8. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

10. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.